Jules Bordet Institute
π§πͺBelgium
- Country
- π§πͺBelgium
- Ownership
- Private
- Established
- 1939-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.bordet.be
Evaluation of Two Techniques for the SLN Detection in BC Patients
- First Posted Date
- 2014-01-10
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 214
- Registration Number
- NCT02032498
- Locations
- π§πͺ
Jules Bordet Institute, Brussels, Belgium
Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy
- First Posted Date
- 2014-01-10
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 20
- Registration Number
- NCT02032563
- Locations
- π§πͺ
Jules Bordet Institute, Brussels, Belgium
Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 55
- Registration Number
- NCT02028364
- Locations
- π§πͺ
CHU Ambroise ParΓ©, Mons, Belgium
π§πͺCliniques Universtaires Saint-Luc, Bruxelles, Belgium
π§πͺinstitut Jules Bordet, Bruxelles, Belgium
NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG
- First Posted Date
- 2014-01-06
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 10
- Registration Number
- NCT02027831
- Locations
- π§πͺ
Jules Bordet Institute, Brussels, Belgium
Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy
- First Posted Date
- 2014-01-06
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 20
- Registration Number
- NCT02027818
- Locations
- π§πͺ
Jules Bordet Institute, Brussels, Belgium
Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer
Completed
- Conditions
- First Posted Date
- 2013-11-26
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 20
- Registration Number
- NCT01995591
- Locations
- π§πͺ
Jules Bordet Institute, Brussels, Belgium
ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 10
- Registration Number
- NCT01993576
- Locations
- π§πͺ
Jules Bordet Insitute, Brussels, Belgium
The Jules Bordet Institute Molecular Profiling Program Feasibility Trial
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-08-30
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 35
- Registration Number
- NCT01932489
- Locations
- π§πͺ
Jules Bordet Institute, Brussels, Belgium
Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-08-28
- Last Posted Date
- 2019-06-25
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 141
- Registration Number
- NCT01929616
- Locations
- π§πͺ
Hopital Erasme, Brussels, Belgium
π§πͺJules Bordet Institute, Brussels, Belgium
π§πͺCentre hospitalier de Jolimont, Lobbes, Belgium
Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-08-06
- Last Posted Date
- 2013-08-06
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 180
- Registration Number
- NCT01916837
- Locations
- π§πͺ
Institut Jules Bordet, Brussels, Belgium
Β© Copyright 2024. All Rights Reserved by MedPath